P/B
28,6
Inovio Pharmaceuticals
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
$125.1M
Market Cap • 10/1/2026
1983
(43 years)
Founded
1998
(28 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
—
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0
EPS
—
Market Cap
Market Cap
125,1M
EV
96,4M
EV/Revenue
0
EV/EBITDA
-1,3
EV/EBIT
-1,2
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-56,1%
Total Yield
-56,1%
Payout
0%
Retained Earnings
-1,8B
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
15,3%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Op. Income 5Y
-17%
CAGR Net Income 5Y
-13,8%
CAGR EPS 5Y
-35,1%
CAGR OCF 5Y
-20,7%
Leverage
N.D./EBITDA
0,4
Debt/Equity
0%
Current Ratio
1
Quick Ratio
0,9
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!